Otto 2001 (unpublished).
Methods | RCT 1993‐1999 | |
Participants | 108 T3, N1‐2, M0 | |
Interventions | Surgery + Adjuvant CT vs. Surgery alone Cisplatin 70mg/m2 Methotrexate 30mg/m2 Vinblastine 3mg/m2 Epirubicin 45mg/m2 3 x 4‐weekly cycles |
|
Outcomes | Survival | |
Notes | Unpublished | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |